Describing Inconsistencies in Pediatric Labeling of Medical Devices.

Area of Science:

• Medical Device Regulation
• Pediatric Safety
• Regulatory Policy

Background:

• The US Food and Drug Administration (FDA) has non-binding recommendations for pediatric age labeling in medical devices, unlike mandatory regulations for drugs.
• This lack of specific labeling contributes to off-label device use, impacting patient safety, risk stratification, clinical practice, marketing, and reimbursement.
• Proper device labeling is crucial for regulatory oversight and effective healthcare delivery.

Purpose of the Study:

• To assess the variability in pediatric age labeling for Class III medical devices approved by the FDA between 2008 and 2017.
• To evaluate adherence to the FDA's non-binding age range recommendations for pediatric labeling.
• To examine device type, clinical application, and inclusion of pediatric populations in clinical trials.

Main Methods:

• A retrospective cross-sectional study analyzing data from FDA public databases and Reports to Congress (2008-2017).
• Two physicians independently reviewed and assigned clinical descriptors to 101 unique devices.
• Descriptive analysis and statistical comparisons (Student t-test) were performed to evaluate labeling and trial data.

Main Results:

• Only 25.7% of devices had specific age ranges, and 50.5% were not indicated for patients under 18.
• A mere 7.9% of devices followed FDA-recommended pediatric age ranges; only 4 used fully structured ranges.
• While 59.4% of trials included pediatric patients, only 32.7% included those under 18 years old.

Conclusions:

• Most high-risk medical devices approved from 2008-2017 were not evaluated or indicated for children under 18.
• This labeling gap creates significant challenges for clinical use, reimbursement, research, and policy.
• The FDA should establish mandatory pediatric labeling requirements for devices, considering age and other critical factors.